Thrombotic and inflammatory markers, including D-dimer, albumin, CRP/ALB ratio, neutrophil and lymphocyte counts, NLR, and LMR, have demonstrated prognostic value for AIS patients undergoing IVT [78,79]. This evidence concerns the gene ALB and androgen insensitivity syndrome.